cupric nitrilotriacetate has been researched along with Cancer of Kidney in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamazaki, S; Hiai, H; Nakashima, Y; Nishiyama, Y; Okada, S; Okamoto, K; Tanaka, T; Toyokuni, S | 1 |
| Athar, M; Giri, U; Iqbal, M | 1 |
2 other study(ies) available for cupric nitrilotriacetate and Cancer of Kidney
| Article | Year |
|---|---|
Induction of renal cell carcinoma in male Wistar rats treated with cupric nitrilotriacetate.
Topics: Animals; Carcinoma, Renal Cell; Copper; Kidney Neoplasms; Male; Nitrilotriacetic Acid; Organometallic Compounds; Rats; Rats, Wistar | 1996 |
Copper-nitrilotriacetate (Cu-NTA) is a potent inducer of proliferative response both in liver and kidney but is a complete renal carcinogen.
Topics: Animals; Carcinogens; Cell Division; Diethylnitrosamine; Kidney Neoplasms; Liver Neoplasms; Male; Mice; Nitrilotriacetic Acid; Organometallic Compounds | 1999 |